Partial correlation network analyses to detect altered gene interactions in human disease: using preeclampsia as a model

• Published in: Human genetics 2011-01, Vol.129 (1), p.25-34
• Main Authors: Johansson, Åsa, Løset, Mari, Mundal, Siv B, Johnson, Matthew P, Freed, Katy A, Fenstad, Mona H, Moses, Eric K, Austgulen, Rigmor, Blangero, John
• Format: Article
• Language: English
• Subjects: Analysis; Biological and medical sciences; Biomedical and Life Sciences; Biomedicine; Cesarean section; Classical genetics, quantitative genetics, hybrids; Correlation analysis; Disease; Diseases of mother, fetus and pregnancy; Female; Fundamental and applied biological sciences. Psychology; Gene expression; Gene Expression Profiling; Gene Expression Regulation; Gene Function; Gene Regulatory Networks; Genes; Genetic transcription; Genetics of eukaryotes. Biological and molecular evolution; Gynecology. Andrology. Obstetrics; Human; Human Genetics; Humans; Hypertension; Infant, Newborn; Male; Medical research; Medical sciences; Metabolic Diseases; Models, Genetic; Molecular Medicine; Original Investigation; Pre-Eclampsia - genetics; Preeclampsia; Pregnancy; Pregnancy. Fetus. Placenta; Transcription, Genetic; Womens health
• ISSN: 0340-6717; 1432-1203; 1432-1203
• DOI: 10.1007/s00439-010-0893-5

Differences in gene expression between cases and controls have been identified for a number of human diseases. However, the underlying mechanisms of transcriptional regulation remain largely unknown. Beyond comparisons of absolute or relative expression levels, disease states may be associated with alterations in the observed correlational patterns among sets of genes. Here we use partial correlation networks aiming to compare the transcriptional co-regulation for 222 genes that are differentially expressed in decidual tissues between preeclampsia (PE) cases and non-PE controls. Partial correlation coefficients (PCCs) have been calculated in cases (N = 37) and controls (N = 58) separately. For all PCCs, we tested if they were significant non-zero in the cases and controls separately. In addition, to examine if a given PCC is different between the cases and controls, we tested if the difference between two PCCs were significant non-zero. In the group with PE cases, only five PCCs were significant (FDR p value ≤ 0.05), of which none were significantly different from the PCCs in the controls. However, in the controls we identified a total of 56 statistically significant PCCs (FDR p value ≤ 0.05), of which 31 were also significantly different (FDR p value ≤ 0.05) from the PCCs in the PE cases. The identified partial correlation networks included genes that are potentially relevant for developing PE, including both known susceptibility genes (EGFL7, HES1) and novel candidate genes (CFH, NADSYN1, DBP, FIGLA). Our results might suggest that disturbed interactions, or higher order relationships between these genes play an important role in developing the disease.